Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-030740

Director acquired 8,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huang James Director 2021-03-04 Grant or award +8,333 8,333 D
Derivatives
Huang James Director 2021-03-04 Grant or award · Stock Option (right to buy) +62,500 62,500 D
Loading xslF345X03/doc4.xml…